News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,416 Results
Type
Article (8016)
Company Profile (140)
Press Release (476259)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166769)
Career Advice (306)
Deals (25740)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9761)
Job Trends (8577)
News (238245)
Policy (17930)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (104)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (262)
Approvals (10367)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3628)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47845)
Collaboration (1239)
Commercialization (3)
Compensation (1447)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (737)
Cystic fibrosis (85)
Data (5624)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73652)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87583)
Executive appointments (697)
FDA (12366)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (910)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (941)
Grass and pollen (2)
Guidances (281)
Healthcare (9314)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8650)
Medtech (8790)
Mergers & acquisitions (14378)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1818)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41209)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15458)
Phase 2 (21369)
Phase 3 (14389)
Pipeline (7218)
Policy (18)
Postmarket research (1570)
Preclinical (6536)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3020)
Recruiting (6)
Regulatory (14790)
Reports (19)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (98)
Last 7 days (433)
Last 30 days (1672)
Last 365 days (19101)
2026 (12041)
2025 (19252)
2024 (22986)
2023 (26538)
2022 (34595)
2021 (37169)
2020 (33470)
2019 (23258)
2018 (17468)
2017 (18765)
2016 (17923)
2015 (24269)
2014 (21683)
2013 (18138)
2012 (20221)
2011 (20440)
2010 (20333)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17885)
Australia (2097)
California (11899)
Canada (3123)
China (517)
Colorado (480)
Connecticut (407)
Delaware (207)
Europe (24614)
Florida (1780)
Georgia (374)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1193)
Massachusetts (7822)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2607)
New Mexico (12)
New York (2806)
North Carolina (1267)
North Dakota (4)
Northern California (5956)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2244)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4941)
Tennessee (119)
Texas (1919)
United States (38646)
Utah (357)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (920)
West Virginia (1)
Wisconsin (73)
484,416 Results for "colorcon inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Colorcon Celebrates Grand Opening of New Manufacturing Facility in Malaysia
July 25, 2025
·
2 min read
Deals
Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging
Colorcon, Inc. announces that it has completed the acquisition of Airnov Healthcare Packaging, Inc. from Arsenal Capital Partners.
March 2, 2023
·
2 min read
Pharm Country
Colorcon, Inc. Launches a New Titanium Dioxide Free Moisture Protection Coating for Pharmaceutical Tablets
Colorcon, a world leader in the development and supply of film coating systems, speciality excipients and functional packaging for the healthcare industries, announces the launch of a new Opadry® film coating system to address the moisture management needs for pharmaceutical tablets, without the use of titanium dioxide.
September 5, 2023
·
1 min read
Pharm Country
Colorcon Ventures Invests in Novome Biotechnologies, an Engineered Microbial Therapy Company
Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Novome Biotechnologies, a clinical-stage company that develops engineered oral microbial therapies.
September 15, 2022
·
2 min read
Pharm Country
Colorcon, Inc. Signs Put Agreement with Intent to Acquire Controlled Atmosphere Packaging Specialist Airnov Healthcare Packaging
Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, announces that it has entered into a Put agreement to purchase Airnov Healthcare Packaging, portfolio company of Arsenal Capital Partners, a private equity firm.
January 23, 2023
·
2 min read
Business
i2O Therapeutics Receives Strategic Investment from Colorcon Ventures and Enters into Research Collaboration with Colorcon
i2O Therapeutics, an innovative biotech company developing a platform to enable oral delivery of traditionally injectable biological drugs, has received a strategic investment from Colorcon Ventures, the corporate venture fund of Colorcon Inc.
December 3, 2020
·
2 min read
Pharm Country
Colorcon, Inc. Launches SoteriaRx™ On-Dose Authentication Technology Platform
Colorcon, a world leader in the development and supply of film coating systems and excipients, announces SoteriaRx™.
May 14, 2020
·
2 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Pharm Country
Colorcon Launches $50 Million Venture Capital Fund
Colorcon, a world leader in the development, supply and technical support of specialty products for the pharmaceutical industry, today announced the establishment of Colorcon Ventures to invest in promising companies in the pharmaceutical industry
September 17, 2019
·
3 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 48,442
Next
